                         SEQUENCE LISTING

<110>  The Wistar Institute of Anatomy and Biology
 
<120>  METHODS AND COMPOSITIONS FOR TREATING CANCER BY TARGETING FATP2 
       AND MYELOID DERIVED SUPPRESSOR CELLS

<130>  WST181PCT

<150>  US 62/808,787
<151>  2019-02-21

<150>  US 62/830,506
<151>  2019-04-07

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  620
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Leu Ser Ala Ile Tyr Thr Val Leu Ala Gly Leu Leu Phe Leu Pro 
1               5                   10                  15      


Leu Leu Val Asn Leu Cys Cys Pro Tyr Phe Phe Gln Asp Ile Gly Tyr 
            20                  25                  30          


Phe Leu Lys Val Ala Ala Val Gly Arg Arg Val Arg Ser Tyr Gly Lys 
        35                  40                  45              


Arg Arg Pro Ala Arg Thr Ile Leu Arg Ala Phe Leu Glu Lys Ala Arg 
    50                  55                  60                  


Gln Thr Pro His Lys Pro Phe Leu Leu Phe Arg Asp Glu Thr Leu Thr 
65                  70                  75                  80  


Tyr Ala Gln Val Asp Arg Arg Ser Asn Gln Val Ala Arg Ala Leu His 
                85                  90                  95      


Asp His Leu Gly Leu Arg Gln Gly Asp Cys Val Ala Leu Leu Met Gly 
            100                 105                 110         


Asn Glu Pro Ala Tyr Val Trp Leu Trp Leu Gly Leu Val Lys Leu Gly 
        115                 120                 125             


Cys Ala Met Ala Cys Leu Asn Tyr Asn Ile Arg Ala Lys Ser Leu Leu 
    130                 135                 140                 


His Cys Phe Gln Cys Cys Gly Ala Lys Val Leu Leu Val Ser Pro Glu 
145                 150                 155                 160 


Leu Gln Ala Ala Val Glu Glu Ile Leu Pro Ser Leu Lys Lys Asp Asp 
                165                 170                 175     


Val Ser Ile Tyr Tyr Val Ser Arg Thr Ser Asn Thr Asp Gly Ile Asp 
            180                 185                 190         


Ser Phe Leu Asp Lys Val Asp Glu Val Ser Thr Glu Pro Ile Pro Glu 
        195                 200                 205             


Ser Trp Arg Ser Glu Val Thr Phe Ser Thr Pro Ala Leu Tyr Ile Tyr 
    210                 215                 220                 


Thr Ser Gly Thr Thr Gly Leu Pro Lys Ala Ala Met Ile Thr His Gln 
225                 230                 235                 240 


Arg Ile Trp Tyr Gly Thr Gly Leu Thr Phe Val Ser Gly Leu Lys Ala 
                245                 250                 255     


Asp Asp Val Ile Tyr Ile Thr Leu Pro Phe Tyr His Ser Ala Ala Leu 
            260                 265                 270         


Leu Ile Gly Ile His Gly Cys Ile Val Ala Gly Ala Thr Leu Ala Leu 
        275                 280                 285             


Arg Thr Lys Phe Ser Ala Ser Gln Phe Trp Asp Asp Cys Arg Lys Tyr 
    290                 295                 300                 


Asn Val Thr Val Ile Gln Tyr Ile Gly Glu Leu Leu Arg Tyr Leu Cys 
305                 310                 315                 320 


Asn Ser Pro Gln Lys Pro Asn Asp Arg Asp His Lys Val Arg Leu Ala 
                325                 330                 335     


Leu Gly Asn Gly Leu Arg Gly Asp Val Trp Arg Gln Phe Val Lys Arg 
            340                 345                 350         


Phe Gly Asp Ile Cys Ile Tyr Glu Phe Tyr Ala Ala Thr Glu Gly Asn 
        355                 360                 365             


Ile Gly Phe Met Asn Tyr Ala Arg Lys Val Gly Ala Val Gly Arg Val 
    370                 375                 380                 


Asn Tyr Leu Gln Lys Lys Ile Ile Thr Tyr Asp Leu Ile Lys Tyr Asp 
385                 390                 395                 400 


Val Glu Lys Asp Glu Pro Val Arg Asp Glu Asn Gly Tyr Cys Val Arg 
                405                 410                 415     


Val Pro Lys Gly Glu Val Gly Leu Leu Val Cys Lys Ile Thr Gln Leu 
            420                 425                 430         


Thr Pro Phe Asn Gly Tyr Ala Gly Ala Lys Ala Gln Thr Glu Lys Lys 
        435                 440                 445             


Lys Leu Arg Asp Val Phe Lys Lys Gly Asp Leu Tyr Phe Asn Ser Gly 
    450                 455                 460                 


Asp Leu Leu Met Val Asp His Glu Asn Phe Ile Tyr Phe His Asp Arg 
465                 470                 475                 480 


Val Gly Asp Thr Phe Arg Trp Lys Gly Glu Asn Val Ala Thr Thr Glu 
                485                 490                 495     


Val Ala Asp Thr Val Gly Leu Val Asp Phe Val Gln Glu Val Asn Val 
            500                 505                 510         


Tyr Gly Val His Val Pro Asp His Glu Gly Arg Ile Gly Met Ala Ser 
        515                 520                 525             


Ile Lys Met Lys Glu Asn His Glu Phe Asp Gly Lys Lys Leu Phe Gln 
    530                 535                 540                 


His Ile Ala Asp Tyr Leu Pro Ser Tyr Ala Arg Pro Arg Phe Leu Arg 
545                 550                 555                 560 


Ile Gln Asp Thr Ile Glu Ile Thr Gly Thr Phe Lys His Arg Lys Met 
                565                 570                 575     


Thr Leu Val Glu Glu Gly Phe Asn Pro Ala Val Ile Lys Asp Ala Leu 
            580                 585                 590         


Tyr Phe Leu Asp Asp Thr Ala Lys Met Tyr Val Pro Met Thr Glu Asp 
        595                 600                 605             


Ile Tyr Asn Ala Ile Ser Ala Lys Thr Leu Lys Leu 
    610                 615                 620 


<210>  2
<211>  102
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  engineered construct

<400>  2
gtccacaata ccgtcgatgt gttttagagc tagaaatagc aagttaaaat aaggctagtc       60

cgttatcaac ttgaaaaagt ggcaccgagt cggtgctttt tt                         102


<210>  3
<211>  102
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  engineered construct

<400>  3
actcctccgt tatatgattg gttttagagc tagaaatagc aagttaaaat aaggctagtc       60

cgttatcaac ttgaaaaagt ggcaccgagt cggtgctttt tt                         102


<210>  4
<211>  160
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  engineered construct

<400>  4
tttactttgt ttgctttgtg tgttttggta aatgtcgaac tgagtccaca ataccgtcga       60

tgtataactt cgtataatgt atgctatacg aagttattgg aaagtggctc gcgtaacaga      120

acaaaatctc aaaacaaatt aacaggaccc cattgctcga                            160


<210>  5
<211>  160
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  engineered construct

<400>  5
atactgtaat ggatggtttt aatattctga taaattaaaa atcactcctc cgttatatga       60

ttgataactt cgtataatgt atgctatacg aagttatagg aaacatatag aattttccag      120

cctagctccg tcttcaaagc ccacgtttct tatacagtgc                            160


<210>  6
<211>  35
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer sequence

<400>  6
ggtggtcccg ggcctatgct gccagtgctc tacac                                  35


<210>  7
<211>  32
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer sequence

<400>  7
ggtggtgtcg actcagagct tcagagtttt at                                     32


